dcvax-direct
Vaccineexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2013 (NCT01882946)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Tumor antigensImmunity, active
immunity, active - tumor antigens
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- dcvax-direct
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03638765 | Phase 1 | Nov 30, 2018 | Mayo Clinic, Northwest Biotherapeutics |
| NCT01882946 | Phase 1/Phase 2 (Phase 2) | Jun 1, 2013 | Northwest Biotherapeutics |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Northwest Biotherapeutics | For profit | 2 | 2 | 2 | 2013 |
| Mayo Clinic | Academic/Hospital | 1 | 0 | 1 | 2018 |
2 organizations
Page 1 / 1